Purinomia Biotech has filed a notice of an exempt offering of securities to raise $1,500,000.00 in Debt Financing.

Purinomia Biotech has filed a notice of an exempt offering of securities to raise $1,500,000.00 in Debt Financing.

Woburn, MA – According to filings with the U.S. Securities and Exchange Commission, Purinomia Biotech is raising $1,500,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Yan Shang played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Purinomia Biotech
Biologicals and small molecule development to target key ectonucleotidases for treatment of cancer, autoimmunity, inflammatory disease and metabolic syndrome.

To learn more about Purinomia Biotech, visit http://purinomia.com/

Contact:
Yan Shang, President and Chief Executive Officer
781-874-0926

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved

Comments are closed.